Antimicrobial and Infectious

Physiopathological Bases and Resistance MechanismsBasics

Benzylpenicillins and IsoxazolylpenicillinsCell Wall Inhibitors

Aminopenicillins and Beta-lactamase InhibitorsBroad Spectrum and Synergistic Combinations

First and Second Generation CephalosporinsBounded Spectrum Wall Inhibitors

Third and Fourth Generation CephalosporinsBroad Spectrum with CSF Penetration

Fifth Generation Cephalosporins and SiderophoresAdvanced Therapies and Extreme Resistance

CarbapenemsUltra-Broad Spectrum Wall Inhibitors

Monobactamics (Aztreonam)Exclusive Gram-Negative Spectrum Wall Inhibitors

Glycopeptides and LipoglycopeptidesSubstrate-Binding Wall Inhibitors

AminoglycosidesProtein Synthesis Inhibitors - 30S

Macrolides and KetolidesProtein Synthesis Inhibitors - 50S

Lincosamides (Clindamycin)Protein Synthesis Inhibitors - 50S

Tetracyclines and GlycylcyclinesExtended Spectrum Protein Synthesis Inhibitors

OxazolidinonesProtein Synthesis Inhibitors - Initiation Phase

Cyclic Lipopeptides and PolymyxinsMembrane Destroyer Agents

FluoroquinolonesInhibitors of Cellular Replication and Topology

Sulfonamides and CotrimoxazoleSynthetic Inhibitors of Metabolic Pathways

Nitroimidazoles (Metronidazole)Nucleic Acid Destroying Agents

Fosfomycin and NitrofuransUrinary Antiseptics and Early Wall Inhibitors

Azole AntifungalsErgosterol Synthesis Inhibitors

Echinocandines and Historical ReservesWall Synthesis Inhibitors and Polyenes

Synthesis: Integrated Antimicrobial Clinical PathwayAtlas of Pharmacoselection and Precision Decisions